中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 42 Issue 6
Jun.  2026
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2026  >  42(6): 1321-1326

Cardiac structure and function in patients with viral， alcoholic or biliary cirrhosis： A comparative study

DOI: 10.12449/JCH260613

  • Functional Department，Hunan Provincial People’s Hospital （The First Affiliated Hospital of Hunan Normal University），Changsha 410000，China

Research funding:

Key Guided Research Project of Hunan Provincial Health Commission (C202303018917)

More Information
  • Corresponding author: FAN Yongmei， fanyongmei@126.com （ORCID： 0000-0003-1234-1067）
  • Received Date: 2025-06-16
  • Accepted Date: 2025-10-11
  • Published Date: 2026-06-25
    Abstract
  •   Objective  To investigate the potential differences in cardiac lesions between the patients with viral， alcoholic or biliary cirrhosis.  Methods  A retrospective analysis was performed for the clinical data of 512 patients who were hospitalized in Hunan Provincial People’s Hospital due to liver cirrhosis from January 2020 to December 2023， and according to the etiology， the patients were divided into viral cirrhosis group with 275 patients， alcoholic cirrhosis group with 70 patients， and biliary cirrhosis group with 167 patients. A one-way analysis of variance was used for comparison of normally distributed continuous data between multiple groups， and the least significant difference t-test or the Tamhane’s T2 test was used based on homogeneity of variance for further comparison between two groups； the Kruskal-Wallis H test was used for comparison of non-normally distributed continuous data between multiple groups； the chi-square test was used for comparison of categorical data between groups.  Results  There was a significant difference in sex distribution between the three groups， and the male patients accounted for 71.3% in the viral cirrhosis group and 95.7% in the alcoholic cirrhosis group， while the female patients accounted for 64.7% in the biliary cirrhosis group. The biliary cirrhosis group had an age of 61.67±9.59 years， which was significantly higher than that in the other two groups （P<0.05）. Compared with the viral cirrhosis group and the biliary cirrhosis group， the alcoholic cirrhosis group had significantly higher Child-Pugh score （H=30.598， P<0.05）， globulin （H=13.350， P<0.05）， and QTc interval （F=9.956， P<0.05） and significantly lower hemoglobin （F=4.529， P<0.05）， prothrombin activity （F=36.293， P<0.05）， and albumin （F=15.744， P<0.05）. There were no significant differences in each echocardiography parameter between the viral cirrhosis group and the alcoholic cirrhosis group （P>0.05）； compared with the biliary cirrhosis group， the viral cirrhosis group and the alcoholic cirrhosis group had significantly larger left atrial anterior-posterior diameter （H=19.197， P<0.05）， left ventricular end-diastolic diameter （LVEDD） （H=15.660， P<0.05）， right atrial transverse diameter （H=22.854， P<0.05）， mid-right ventricular transverse diameter （H=10.936， P<0.05）， interventricular septal thickness in diastole （IVSd） （H=13.539， P<0.05）， and left ventricular posterior wall thickness in diastole （LVPWd） （H=14.139， P<0.05）； compared with the biliary cirrhosis group， the viral cirrhosis group had a significantly higher mitral ratio of peak early to late diastolic filling velocity （E/A） （P<0.05）. Left ventricular diastolic dysfunction was observed in 170 patients （61.8%） in the viral cirrhosis group， 45 patients （64.3%） in the alcoholic cirrhosis group， and 125 patients （74.9%） in the biliary cirrhosis group， with a significant difference between the three groups （χ2=8.074， P=0.018）. The patients were divided into grade A， B， and C groups based on Child-Pugh score， and comparisons of echocardiography findings between the three groups showed no significant differences in LVEDD， IVSd， LVPWd， E/A， and left ventricular ejection fraction （all P>0.05）.  Conclusion  There are differences in cardiac structure and function between patients with different etiologies of liver cirrhosis， and in clinical practice， individualized cardiac assessment and intervention should be performed based on different etiologies.

     

    • FullText(HTML)
  • loading
    • References(30)
  • [1]
    Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35( 11): 2408- 2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.

    中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35( 11): 2408- 2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
    [2]
    STUNDIENE I, SARNELYTE J, NORKUTE A, et al. Liver cirrhosis and left ventricle diastolic dysfunction: Systematic review[J]. World J Gastroenterol, 2019, 25( 32): 4779- 4795. DOI: 10.3748/wjg.v25.i32.4779.
    [3]
    MØLLER S, DANIELSEN KV, WIESE S, et al. An update on cirrhotic cardiomyopathy[J]. Expert Rev Gastroenterol Hepatol, 2019, 13( 5): 497- 505. DOI: 10.1080/17474124.2019.1587293.
    [4]
    FERNÁNDEZ-SOLÀ J. The effects of ethanol on the heart: Alcoholic cardiomyopathy[J]. Nutrients, 2020, 12( 2): 572. DOI: 10.3390/nu12020572.
    [5]
    DOURAKIS SP, GELADARI E, GELADARI C, et al. Cirrhotic cardiomyopathy: The interplay between liver and cardiac muscle. how does the cardiovascular system react when the liver is diseased?[J]. Curr Cardiol Rev, 2021, 17( 1): 78- 84. DOI: 10.2174/1573403X15666190509084519.
    [6]
    LI M, SU JT, WU SS, et al. Correlation among age, sex, and liver diseases-related mortality risk in patients with hepatitis B virus-related liver cirrhosis[J]. Chin J Hepatol, 2021, 29( 5): 403- 408. DOI: 10.3760/cma.j.cn501113-20201224-00676.

    李敏, 苏健婷, 武珊珊, 等. 乙型肝炎肝硬化患者年龄和性别与肝病相关死亡风险的关系[J]. 中华肝脏病杂志, 2021, 29( 5): 403- 408. DOI: 10.3760/cma.j.cn501113-20201224-00676.
    [7]
    ZHONG ZW, ABASSA K, CHEN R, et al. Prognostic value of MELD 3.0 based model for survival outcomes in alcoholic cirrhosis patients[J]. J Sun Yat Sen Univ Med Sci, 2025, 46(2): 318-327. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2025.0216.
    [8]
    LI L, LIU ZS. Progress in surgical treatment of hepatolithiasis complicated with portal hypertension[J]. Med J West China, 2011, 23( 4): 780- 781. DOI: 10.3969/j.issn.1672-3511.2011.04.084.

    李莉, 刘志苏. 肝胆管结石合并门脉高压症的外科治疗进展[J]. 西部医学, 2011, 23( 4): 780- 781. DOI: 10.3969/j.issn.1672-3511.2011.04.084.
    [9]
    JAHANGIRI S, ABDIARDEKANI A, JAMSHIDI S, et al. Electrocardiographic characteristics of cirrhotic patients and their association with Child-Pugh score[J]. Clin Cardiol, 2023, 46( 8): 967- 972. DOI: 10.1002/clc.24089.
    [10]
    PAPADOPOULOS VP, MIMIDIS K. Corrected QT interval in cirrhosis: A systematic review and meta-analysis[J]. World J Hepatol, 2023, 15( 9): 1060- 1083. DOI: 10.4254/wjh.v15.i9.1060.
    [11]
    BARUTCU S, INANC I, SABANOGLU C, et al. Predictive value of Tp-e interval, Tp-e/QT, and Tp-e/QTc for disease severity in patients with liver cirrhosis[J]. Eur Rev Med Pharmacol Sci, 2023, 27( 3): 1110- 1120. DOI: 10.26355/eurrev_202302_31214.
    [12]
    OU M, TIAN Y, ZHUANG GQ, et al. QTc interval prolongation in liver cirrhosis with upper gastrointestinal bleeding[J]. Med Clínica, 2021, 156( 2): 68- 75. DOI: 10.1016/j.medcli.2020.06.059.
    [13]
    TOMA L, STANCIU AM, ZGURA A, et al. Electrocardiographic changes in liver cirrhosis-clues for cirrhotic cardiomyopathy[J]. Medicina, 2020, 56( 2): 68. DOI: 10.3390/medicina56020068.
    [14]
    LI Y, LI SH, WANG QQ, et al. Predictive value of QTc for short-term prognosis in patients with cirrhotic ascites[J]. J Clin Hepatol, 2025, 41( 7): 1371- 1379. DOI: 10.12449/JCH250722.

    李叶, 李生浩, 王晴晴, 等. QTc间期对肝硬化腹水患者短期预后的预测价值[J]. 临床肝胆病杂志, 2025, 41( 7): 1371- 1379. DOI: 10.12449/JCH250722.
    [15]
    RUÍZ-DEL-ÁRBOL L, ACHÉCAR L, SERRADILLA R, et al. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine[J]. Hepatology, 2013, 58( 5): 1732- 1741. DOI: 10.1002/hep.26509.
    [16]
    YE YL, QUAN MZ, YE P, et al. Abnormal changes of electrocardiogram and Doppler echocardiographic parameters in patients with liver cirrhosis[J]. J Pract Hepatol, 2016, 19( 5): 574- 577. DOI: 10.3969/j.issn.1672-5069.2016.05.016.

    叶玉玲, 权明珠, 叶萍, 等. 乙型肝炎肝硬化患者心电图和超声心动图检查异常及其临床意义[J]. 实用肝脏病杂志, 2016, 19( 5): 574- 577. DOI: 10.3969/j.issn.1672-5069.2016.05.016.
    [17]
    ZHANG XH, MENG FK. The application of stress echocardiography in evaluating left heart function reserve in patients with liver cirrhosis[J]. Chin Hepatol, 2024, 29( 8): 910- 913, 938. DOI: 10.14000/j.cnki.issn.1008-1704.2024.08.008.

    张旭辉, 孟繁坤. 负荷超声心动图在评估肝硬化患者左心功能储备中的应用[J]. 肝脏, 2024, 29( 8): 910- 913, 938. DOI: 10.14000/j.cnki.issn.1008-1704.2024.08.008.
    [18]
    MATSUMORI A. Symposium on clinical aspects in hepatitis virus infection. 5. Clinical practice of hepatitis: Myocardial diseases, nephritis, and vasculitis associated with hepatitis virus[J]. Intern Med, 2001, 40( 2): 182- 184. DOI: 10.2169/internalmedicine.40.182.
    [19]
    DEMIR M, DEMIR C. Effect of hepatitis B virus infection on right and left ventricular functions[J]. Med Sci Monit, 2012, 18( 9): CR587- CR591. DOI: 10.12659/msm.883356.
    [20]
    RODRIGUES P, SANTOS-RIBEIRO S, TEODORO T, et al. Association between alcohol intake and cardiac remodeling[J]. J Am Coll Cardiol, 2018, 72( 13): 1452- 1462. DOI: 10.1016/j.jacc.2018.07.050.
    [21]
    KOZHEVNIKOVA LM, TSORIN IB, STOLYARUK VN, et al. Epac proteins and calmodulin as possible arrhythmogenesis trigger in alcoholic cardiomyopathy[J]. Bull Exp Biol Med, 2018, 165( 5): 613- 616. DOI: 10.1007/s10517-018-4225-4.
    [22]
    RAM P, LO KB, SHAH M, et al. National trends in hospitalizations and outcomes in patients with alcoholic cardiomyopathy[J]. Clin Cardiol, 2018, 41( 11): 1423- 1429. DOI: 10.1002/clc.23067.
    [23]
    PAPASTERGIOU V, SKORDA L, LISGOS P, et al. Ultrasonographic prevalence and factors predicting left ventricular diastolic dysfunction in patients with liver cirrhosis: Is there a correlation between the grade of diastolic dysfunction and the grade of liver disease?[J]. Sci World J, 2012, 2012: 615057. DOI: 10.1100/2012/615057.
    [24]
    SAMPAIO F, PIMENTA J, BETTENCOURT N, et al. Systolic and diastolic dysfunction in cirrhosis: A tissue-Doppler and speckle tracking echocardiography study[J]. Liver Int, 2013, 33( 8): 1158- 1165. DOI: 10.1111/liv.12187.
    [25]
    ZHOU JM, CUI XT, JIN XJ, et al. Association of renal biochemical parameters with left ventricular diastolic dysfunction in a community-based elderly population in China: A cross-sectional study[J]. PLoS One, 2014, 9( 2): e88638. DOI: 10.1371/journal.pone.0088638.
    [26]
    DESWAL A. Diastolic dysfunction and diastolic heart failure: Mechanisms and epidemiology[J]. Curr Cardiol Rep, 2005, 7( 3): 178- 183. DOI: 10.1007/s11886-005-0074-7.
    [27]
    MITTAL C, QURESHI W, SINGLA S, et al. Pre-transplant left ventricular diastolic dysfunction is associated with post transplant acute graft rejection and graft failure[J]. Dig Dis Sci, 2014, 59( 3): 674- 680. DOI: 10.1007/s10620-013-2955-8.
    [28]
    MOON YJ, KIM JW, BANG YS, et al. Prediction of all-cause mortality after liver transplantation using left ventricular systolic and diastolic function assessment[J]. PLoS One, 2019, 14( 1): e0209100. DOI: 10.1371/journal.pone.0209100.
    [29]
    JOSEFSSON A, FU M, ALLAYHARI P, et al. Impact of peri-transplant heart failure& left-ventricular diastolic dysfunction on outcomes following liver transplantation[J]. Liver Int, 2012, 32( 8): 1262- 1269. DOI: 10.1111/j.1478-3231.2012.02818.x.
    [30]
    CAI J, ZHAO YT. Quantitative evaluation of cardiac function in patients with liver cirrhosis by echocardiography and its relationship with liver function indicators[J]. Med Innov China, 2022, 19( 10): 143- 147. DOI: 10.3969/j.issn.1674-4985.2022.10.034.

    蔡晶, 赵一婷. 超声心动图定量评估肝硬化患者心功能的情况及其与肝功能指标的关系[J]. 中国医学创新, 2022, 19( 10): 143- 147. DOI: 10.3969/j.issn.1674-4985.2022.10.034.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (37) PDF downloads(16) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return